It has recently been recognized that intrinsically disordered proteins are involved in a range of functional roles in the cell, as well as being associated with a number of diverse diseases, including cancers, neurodegenerative disorders, and cardiac myopathies.  We use single molecule fluorescence approaches to characterize both the ‘structures’ and dynamics of disordered proteins implicated in the progression of Parkinson's and  Alzheimer's diseases. Our goal is to understand how disease-associated modifications to these proteins alter their conformational and dynamic properties and to relate these changes to disease pathology.